Compare VMRK & HUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VMRK | HUM |
|---|---|---|
| Founded | 1978 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.8B | 50.1B |
| IPO Year | 1994 | 2002 |
| Metric | VMRK | HUM |
|---|---|---|
| Price | $62.12 | $411.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 26 |
| Target Price | $71.62 | ★ $465.13 |
| AVG Volume (30 Days) | ★ 4.1M | 1.2M |
| Earning Date | 11-04-2026 | 11-06-2026 |
| Dividend Yield | ★ 4.55% | 0.85% |
| EPS Growth | ★ 8.09 | N/A |
| EPS | 0.54 | ★ 9.83 |
| Revenue | $2,701,075,000.00 | ★ $129,664,000,000.00 |
| Revenue This Year | $42.39 | $25.51 |
| Revenue Next Year | $51.23 | $3.65 |
| P/E Ratio | $114.33 | ★ $42.04 |
| Revenue Growth | 4.76 | ★ 10.11 |
| 52 Week Low | $58.64 | $163.11 |
| 52 Week High | $66.45 | $456.50 |
| Indicator | VMRK | HUM |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 50.34 |
| Support Level | $58.64 | $407.50 |
| Resistance Level | $62.26 | $419.36 |
| Average True Range (ATR) | 1.08 | 13.31 |
| MACD | 0.17 | -1.87 |
| Stochastic Oscillator | 47.55 | 10.28 |
Vivmark owns a high-quality apartment portfolio with around 184,000 units and is developing another $4.4 billion of residential properties. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.